Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
Atypical chronic myeloid leukemia is a rare disease whose pathogenesis has long been debated. It currently belongs to the group of myelodysplastic/myeloproliferative disorders. In this review, an overview on the current knowledge about diagnosis, prognosis, and genetics is presented, with a major fo...
Enregistré dans:
Auteurs principaux: | Diletta Fontana, Carlo Gambacorti-Passerini, Rocco Piazza |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/861bc3225c5d4c17958485b0290ca4f5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview
par: Andrea Kuendgen, et autres
Publié: (2021) -
TRANSCRIPTOS DE FUSIÓN DEL GEN BCR/ABL EN PACIENTES CON LEUCEMIA MIELOIDE CRÓNICA
par: Artigas,Carmen Gloria, et autres
Publié: (2003) -
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
par: Amin Huma, et autres
Publié: (2021) -
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
par: Oksana Montecchini, et autres
Publié: (2021) -
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
par: Haidée Aranda-Tavío, et autres
Publié: (2021)